RNS Number:6215F
Novartis Pharma AG
04 July 2006
FORM 8.1
DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note 1) Novartis Pharma AG
Company dealt in NeuTec Pharma Plc
Class of relevant security to which the Ordinary shares
dealings being disclosed relate (Note 2)
Date of dealing 3 July 2006
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long
Short
Number Number
(%)
(%)
(1) Relevant securities 2,409,896 8.29%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total 2,409,896 8.29%
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long
Short
Number Number
(%)
(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit
(Note 5)
Purchase 2,000 10.40 GBP
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 6) Number of securities (Note 7) Price per
unit (Note 5)
e.g. CFD
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g.
Expiry Option money
purchasing, to which the option American,
e.g. call option varying etc. relates (Note 7) price European etc. date
paid/received per
unit (Note 5)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price
per unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit
(if applicable) (Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating
to the voting rights of any relevant securities under any option referred to on this form or
relating to the voting
rights or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure 4 July 2006
Contact name John Manser
Telephone number 00 41 61 324 11 11
Name of offeree/offeror with which associated Novartis Pharma AG
Specify category and nature of associate status (Note 10) N/A
Notes
The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCSSWFSLSMSEEW
|